1. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE: Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014, 103: 137-149. 10.1016/j.diabres.2013.11.002.
2. World Health Organization: Prevention of blindness from diabetes mellitus: report of a WHO consultation in Geneva, Switzerland, 9-11 November 2005. 2006, Geneva: World Health Organization
3. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, Haffner S, Hamman RF, Ikram MK, Kayama T, Klein BE, Klein R, Krishnaiah S, Mayurasakorn K, O'Hare JP, Orchard TJ, Porta M, Rema M, Roy MS, Sharma T, Shaw J, Taylor H, Tielsch JM, Varma R, Wang JJ, Wang N, et al: Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012, 35: 556-564. 10.2337/dc11-1909.
4. Mohamed Q, Gillies MC, Wong TY: Management of diabetic retinopathy: a systematic review. JAMA. 2007, 298: 902-916. 10.1001/jama.298.8.902.
5. World Health Organization: Diabetes Surveillance. Source: The National Expert Committee on NCD. Non-communicable diseases in Nigeria. Final report of a national survey. Federal Ministry of Health and Social Services, 1997. WHO Global Infobase Version: 1292beta IBRef 100935a1. 2005, 25-26. nigeria_ndm_countryprofile.pdf. http://www.afro.who.int/en/downloads/doc_download/2528-nigeria.html . Last accessed 23 December 2014